Pfizer beats 3Q profit forecasts


On a per-share basis, the New York company posted a profit of 47 cents Tuesday. Earnings, adjusted for non-recurring costs and costs related to mergers and acquisitions, came to 67 cents per share, or 2 cents better than expected, according to a survey by Zacks Investment Research.



from Biotech News